04:48 AM EDT, 05/10/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) reported Q1 adjusted net income late Thursday of $1.45 per diluted share, up from $1.32 a year earlier.

Analysts polled by Capital IQ expected $1.47.

Net revenue for the quarter ended March 31 was $144.9 million, compared with $144.8 million a year earlier.

Analysts surveyed by Capital IQ expected $146.9 million.

For 2024, the company reaffirmed its revenue guidance of $580 million to $595 million. Analysts polled by Capital IQ expect $582.3 million.

Price: 36.50, Change: -1.36, Percent Change: -3.59